Medical Device Dec 3, 2025
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Class II FDA: Ongoing B Braun Medical Inc.
Medical Device Dec 3, 2025
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Class II FDA: Ongoing B Braun Medical Inc.
Medical Device Dec 3, 2025
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Class II FDA: Ongoing B Braun Medical Inc.
Medical Device Dec 3, 2025
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Class II FDA: Ongoing B Braun Medical Inc.
Medical Device Dec 3, 2025
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Class II FDA: Ongoing B Braun Medical Inc.
Medical Device Dec 3, 2025
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Class II FDA: Ongoing B Braun Medical Inc.
Medical Device Dec 3, 2025
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Class II FDA: Ongoing B Braun Medical Inc.
Medical Device Dec 3, 2025
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Class II FDA: Ongoing B Braun Medical Inc.
Medical Device Dec 3, 2025
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Class II FDA: Ongoing B Braun Medical Inc.
Medical Device Dec 3, 2025
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Class II FDA: Ongoing B Braun Medical Inc.
Medical Device Dec 3, 2025
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Class II FDA: Ongoing B Braun Medical Inc.
Medical Device Dec 3, 2025
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Class II FDA: Ongoing B Braun Medical Inc.
Medical Device Dec 3, 2025
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Class II FDA: Ongoing B Braun Medical Inc.
Medical Device Dec 3, 2025
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Class II FDA: Ongoing B Braun Medical Inc.
Medical Device Dec 3, 2025
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Class II FDA: Ongoing B Braun Medical Inc.
Medical Device Dec 3, 2025
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Class II FDA: Ongoing B Braun Medical Inc.
Medical Device Dec 3, 2025
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Class II FDA: Ongoing B Braun Medical Inc.
Medical Device Dec 3, 2025
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Class II FDA: Ongoing B Braun Medical Inc.
Medical Device Oct 29, 2025
The potential for micro-air bubbles observed in the bloodline and air-in-line alarms due to damaged arterial and venous patient connectors.
Class I FDA: Ongoing B BRAUN MEDICAL Inc.
Medical Device Oct 15, 2025
Potential for the lid of the catheter connector to be in the incorrect position.
Class II FDA: Ongoing B BRAUN MEDICAL Inc.
Medical Device Oct 15, 2025
Potential for the lid of the catheter connector to be in the incorrect position.
Class II FDA: Ongoing B BRAUN MEDICAL Inc.
Medical Device Oct 15, 2025
Potential for the lid of the catheter connector to be in the incorrect position.
Class II FDA: Ongoing B BRAUN MEDICAL Inc.
Medical Device Oct 15, 2025
Potential for the lid of the catheter connector to be in the incorrect position.
Class II FDA: Ongoing B BRAUN MEDICAL Inc.
Medical Device Oct 15, 2025
Potential for the lid of the catheter connector to be in the incorrect position.
Class II FDA: Ongoing B BRAUN MEDICAL Inc.
Understanding this recall history This page summarizes recall records in which the official source identifies B. Braun Medical, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.